logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

巴西一天增2萬確診 政府批准使用「羥氯喹」

根據巴西衛生部公佈的最新數據,該國單日新增新冠肺炎確診病例19,951例,創下自疫情在該國暴發以來的單日最大增幅,目前巴西新冠肺炎確診總數居全球第三位,僅次於美國、俄羅斯。 

截至當地時間5月20日19時,巴西全國共有新冠肺炎確診病例291,579例,比前一日新增19,951例,創下自疫情在巴西暴發以來的單日最大增幅,死亡病例18,859例,新增死亡病例888例。全球的統計數字在24小時內,新增了10萬6千例確診。根據世界衛生組織WHO的報告,這也是歷來單日新增最多的一天,其中有三分之二集中在美國、俄羅斯、巴西和印度。

儘管巴西死亡病例數字飆升,巴西總統波索納洛仍然宣稱,新冠病毒疾病只不過像是小感冒,他也不把「維持社交距離」的措施看在眼裡。專家批評,巴西總統在面對這樣的醫療危機時,心態混亂、一昧否認,先前在一個月內已經有兩任衛生部長相繼辭職,巴西對抗疫情的工作雪上加霜。

巴西總統波索納洛無視國內醫學界警告,一向強力支持抗瘧疾藥物奎寧治療新冠肺炎。巴西衛生部週三批准擴大其用途,讓輕症患者也可使用。但患者或家屬必須簽署免責書,承認藥物可能引致潛在的副作用。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 羅斯福號停關島近2個月 今出海訓練準備執行任務
Next post 中央公園視頻涉種族主義 相關女子被解僱

即時新聞

俄克拉荷馬州發生氨氣洩漏事故 數十人送醫

November 13, 2025

紐約市議會通過法案 擴大路邊垃圾箱投放範圍

November 13, 2025

加州50號提案涉種族歧視 司法部提訴訟

November 13, 2025

抗議勞資談判缺乏進展 星巴克65家門市罷工

November 13, 2025

川普簽署撥款法案 結束43天創紀錄政府停擺

November 13, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy